/
/
/

Accretion Pharmaceuticals Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)201.90
Volume (₹)68,400.00
High (₹)210.00
Upper Circuit210.00
Low (₹)201.90
Lower Circuit190.00
Prev Close200.00
52W High (₹)214.70
Price210.00
52W Low (₹)53.80

Share Market Cap & Key Ratios Overview

M.Cap (₹)222.32 Cr
Div. Yield (%)0.00
PE Ratio23.00
Debt to Equity0.24
Price to Book1.35
Book Value46.91
EPS (TTM)8.70
Face Value10.00
ROE (%)28.72

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
CIPLANSE
ZYDUSLIFENSE
LAURUSLABSNSE
LUPINNSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
ACCPL-STNSE
LTP
1W Low
1W High
Market cap (₹)
1895-36.7 (-1.90%)
1883.10
1936.80
4,55,634Cr
9315+95 (1.03%)
9100
9315
2,41,576Cr
4914-98 (-1.96%)
4823
5025
1,84,478Cr
1395-17.8 (-1.26%)
1375.50
1415.40
1,11,888Cr
1156.9+2.7 (0.23%)
1114.10
1163
1,11,820Cr
1876.7+12.7 (0.68%)
1832.70
1876.70
99,418Cr
2105-50.2 (-2.33%)
2095.60
2159.90
96,529Cr
1144.2-12.3 (-1.06%)
1141.80
1166.80
96,322Cr
2318-73.5 (-3.07%)
2303.50
2390
96,180Cr
1660+11.8 (0.72%)
1622.60
1668
95,127Cr
210+5 (2.44%)
200
210
222Cr

Key Highlights of Accretion Pharmaceuticals Ltd Balance Sheet

Accretion Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹11.12Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹11.12Cr, and the reserves and surplus of the company is ₹43.59Cr.

The company has its non-current liabilities with total liabilities of ₹76.68Cr as of 2026-03-31.

The current liabilities are ₹20.84Cr as of 2026-03-31. At the same time, current assets are ₹60.4Cr as of 2026-03-31.